Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma

Completed · Phase 2

Conditions studied: Non-Hodgkin Lymphoma

In brief

The purpose of this study is to determine the complete response rate when CHOP-R chemotherapy in followed by Zevalin in previous untreated patients with follicular lymphoma

Key facts

Study ID

NCT00177554

Run by

University of Pittsburgh

People needed

60

Starts

2003-11-01

Expected to finish

2007-05-01

Last updated by the study team

2008-05-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Conformed diagnosis of follicular lymphoma, grades 1,2 or 3
• No prior chemotherapy
• No prior monoclonal antibody therapy
• Bulky or symptomatic disease, stage II-IV
• Performance status 0-2

You may not qualify if…

• Impaired bone marrow reserve
• Presence of CNS lymphoma
• Serious nonmalignant disease or active infection

Where it is running

• UPMC Cancer Centers — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.